Interventions to improve medication adherence in mental health: the update of a systematic review of cost-effectiveness

References

• Agarwal R, Gupta A, Fendrick AM. 2018. Value-based insurance design improves medication adherence without an increase in total health care spending. Health Aff (Millwood)) 37(7):1057–1064.
   PubMed Web of Science ®Google Scholar
• Akerblad A-C, Bengtsson F, Ekselius L, von Knorring L. 2003. Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners. Int Clin Psychopharmacol. 18(6):347–354.
   PubMed Web of Science ®Google Scholar
• Bosmans JE, Brook OH, van Hout HPJ, de Bruijne MC, Nieuwenhuyse H, Bouter LM, Stalman WAB, van Tulder MW. 2007. Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants. Pharmacoeconomics. 25(1):25–37.
   PubMed Web of Science ®Google Scholar
• Brook OH, van Hout H, Stalman W, Nieuwenhuyse H, Bakker B, Heerdink E, de Haan M. 2005. A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients. Psychiatr Serv. 56(4):487–489.
   PubMed Web of Science ®Google Scholar
• CCEMG—EPPI-Centre Cost - Converter v. 1.6. 2019. The Campbell and Cochrane Economics Methods Group (CCEMG) and the Evidence for Policy and Practice Information and Coordinating Centre (EPPI-Centre). [Internet]. [cited 2019 Aug 24]. Available from: https://eppi.ioe.ac.uk/costconversion/
   Google Scholar
• Chong HY, Teoh SL, Wu D-C, Kotirum S, Chiou C-F, Chaiyakunapruk N. 2016. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 12:357–373.
   PubMed Web of Science ®Google Scholar
• Cleemput I, Kesteloot K, DeGeest S. 2002. A review of the literature on the economics of noncompliance. Health Policy. 59(1):65–94.
   PubMed Web of Science ®Google Scholar
• Conn VS, Ruppar TM, Enriquez M, Cooper P. 2016. Medication adherence interventions that target subjects with adherence problems: systematic review and meta-analysis. Res Social Adm Pharm. 12(2):218–246.
   PubMed Web of Science ®Google Scholar
• Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. 2008. Medication compliance and persistence: terminology and definitions. Value Heal. 11(1):44–47.
   PubMed Web of Science ®Google Scholar
• Crowe M, Porter R, Inder M, Lacey C, Carlyle D, Wilson L. 2012. Effectiveness of interventions to improve medication adherence in bipolar disorder. Aust N Z J Psychiatry. 46(4):317–326.
   PubMed Web of Science ®Google Scholar
• Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. 2018. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 8(1):e016982.
   PubMed Web of Science ®Google Scholar
• Czobor P, Van Dorn RA, Citrome L, Kahn RS, Fleischhacker WW, Volavka J. 2015. Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies. Eur Neuropsychopharmacol. 25(8):1158–1166.
   PubMed Web of Science ®Google Scholar
• Del Pino-Sedeño T, Peñate W, de Las Cuevas C, Valcarcel-Nazco C, Fumero A, Serrano-Pérez PG, Acosta Artiles FJ, Ramos García V, León Salas B, Bejarano-Quisoboni D, et al. 2019. Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders - MAPDep: a study protocol for a cluster randomized controlled trial. Patient Prefer Adherence. 13:309–319.
   PubMed Web of Science ®Google Scholar
• Demyttenaere K. 2003. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol. 13(Suppl 3):S69–S75.
   PubMed Web of Science ®Google Scholar
• Desai R, Nayak R. 2019. Effects of medication nonadherence and comorbidity on health resource utilization in schizophrenia. JMCP. 25(1):37–44A.
   PubMed Web of Science ®Google Scholar
• Di Lorenzo R, Sagona M, Landi G, Martire L, Piemonte C, Del Giovane C. 2016. The revolving door phenomenon in an italian acute psychiatric ward: a 5-year retrospective analysis of the potential risk factors. J Nerv Ment Dis. 204(9):686–692. Sep
   PubMed Web of Science ®Google Scholar
• Dilla T, Ciudad A, Álvarez M. 2013. Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Patient Prefer Adherence. 7:275–284.
   PubMed Web of Science ®Google Scholar
• Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, Reed SD, Rutten F, Sculpher M, Severens J, et al. 2009. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value Health. 12(4):409–418.
   PubMed Web of Science ®Google Scholar
• Drummond MF, Jefferson TO. 1996. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 313(7052):275–283.
   PubMed Web of Science ®Google Scholar
• Drummond MF, Sculpher MJ, Torrance GW, O’Brien SB. 2005. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
   Google Scholar
• Elliott RA, Barber N, Horne R. 2005. Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence. Ann Pharmacother. 39(3):508–515.
   PubMed Web of Science ®Google Scholar
• Fagerness J, Fonseca E, Hess GP, Scott R, Gardner KR, Koffler M, et al. 2014. Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings. Am J Manag Care. 20(5):e146–e156.
   PubMed Web of Science ®Google Scholar
• García-Pérez L, Linertová R, Arvelo-Martín A, Guerra-Marrero C, Martínez-Alberto CE, Cuéllar-Pompa L, Escobar A, Serrano-Aguilar P. 2017. Methodological quality of economic evaluations alongside trials of knee physiotherapy. Int J Technol Assess Health Care. 33(4):454–459.
   PubMed Web of Science ®Google Scholar
• García-Pérez L, Serrano-Aguilar P. 2011. Cost-effectiveness of interventions to enhance medication adherence in psychiatric patients: a systematic review. Curr Clin Pharmacol. 6(2):115–124.
   PubMedGoogle Scholar
• Gibson S, Brand SL, Burt S, Boden ZVR, Benson O. 2013. Understanding treatment non-adherence in schizophrenia and bipolar disorder: a survey of what service users do and why. BMC Psychiatry. 13:153.
   PubMed Web of Science ®Google Scholar
• Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV. 2004. Adherence to treatment with antipsychotic medication and health care costs among medicaid beneficiaries with schizophrenia. Am J Psychiatry. 161(4):692–699.
   PubMed Web of Science ®Google Scholar
• Gong W, Xu D, Zhou L, Brown HS, Smith KL, Xiao S. 2014. Village doctor-assisted case management of rural patients with schizophrenia: Protocol for a cluster randomized control trial. Implement Sci. 9(1):1–10.
   PubMedGoogle Scholar
• Gray R, Bressington D, Ivanecka A, Hardy S, Jones M, Schulz M, von Bormann S, White J, Anderson KH, Chien W-T, et al. 2016. Is adherence therapy an effective adjunct treatment for patients with schizophrenia spectrum disorders? A systematic review and meta-analysis. BMC Psychiatry. 16(1):90.
   PubMedGoogle Scholar
• Haynes B, Ackloo E, Sahota N, McDonald H, Yao X. 2008. Interventions for enhancing medication adherence (Review) - The cochrane collaboration. Wiley. 2(2):100.
   Google Scholar
• Healey A, Knapp M, Astin J, Beecham J, Kemp R, Kirov G, David A. 1998. Cost-effectiveness evaluation of compliance therapy for people with psychosis. Br J Psychiatry. 172(5):420–424.
   PubMedGoogle Scholar
• Henderson C, Knapp M, Yeeles K, Bremner S, Eldridge S, David AS, O’Connell N, Burns T, Priebe S. 2015. Cost-effectiveness of financial incentives to promote adherence to depot antipsychotic medication: economic evaluation of a cluster-randomised controlled trial. PLoS One. 10(10):e0138816.
   PubMed Web of Science ®Google Scholar
• Ho SC, Chong HY, Chaiyakunapruk N, Tangiisuran B, Jacob SA. 2016. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review. J Affect Disord. 193:1–10.
   PubMed Web of Science ®Google Scholar
• Hughes D, Cowell W, Koncz T, Cramer J, International Society for Pharmacoeconomics & Outcomes Research Economics of Medication Compliance Working Group 2007. Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations. Value Health. 10(6):498–509.
   PubMed Web of Science ®Google Scholar
• Julius RJ, Novitsky MA, Dubin WR. 2009. Medication adherence: a review of the literature and implications for clinical practice. J Psychiatr Pract. 15(1):34–44.
   PubMed Web of Science ®Google Scholar
• Kane JM, Kishimoto T, Correll CU. 2013. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry. 12(3):216–226.
   PubMed Web of Science ®Google Scholar
• Katon W, Russo J, Korff M, Lin E, Simon G, Bush T, Ludman E, Walker E. 2002. Long-term effects of a collaborative care intervention in persistently depressed primary care patients. J Gen Intern Med. 17(10):741–748.
   PubMed Web of Science ®Google Scholar
• Kemp R, Kirov G, Everitt B, Hayward P, David A. 1998. Randomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry. 172:413–419.
   PubMed Web of Science ®Google Scholar
• Knapp M, King D, Pugner K, Lapuerta P. 2004. Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry. 184(June):509–516.
   PubMedGoogle Scholar
• Leclerc E, Mansur RB, Brietzke E. 2013. Determinants of adherence to treatment in bipolar disorder: a comprehensive review. J Affect Disord. 149(1-3):247–252.
   PubMed Web of Science ®Google Scholar
• Marcus SC, Olfson M. 2008. Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophr Bull. 34(1):173–180.
   PubMed Web of Science ®Google Scholar
• Masand P, Narasimhan M. 2006. Improving adherence to antipsychotic pharmacotherapy. Curr Clin Pharmacol. 1(1):47–56.
   PubMedGoogle Scholar
• Meehan J, Kapur N, Hunt IM, Turnbull P, Robinson J, Bickley H, Parsons R, Flynn S, Burns J, Amos T, et al. 2006. Suicide in mental health in-patients and within 3 months of discharge. National clinical survey. Br J Psychiatry. 188:129–134.
   PubMed Web of Science ®Google Scholar
• Milosavljevic A, Aspden T, Harrison J. 2018. Community pharmacist-led interventions and their impact on patients’ medication adherence and other health outcomes: a systematic review. Int J Pharm Pract. 26(5):387–397.
   PubMed Web of Science ®Google Scholar
• Murru A, Pacchiarotti I, Amann BL, Nivoli AMA, Vieta E, Colom F. 2013. Treatment adherence in bipolar I and schizoaffective disorder, bipolar type. J Affect Disord. 151(3):1003–1008.
   PubMed Web of Science ®Google Scholar
• Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Mulder CL. 2018. Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial. BMC Res Notes. 11(1):655.
   PubMedGoogle Scholar
• Noordraven EL, Wierdsma AI, Blanken P, Bloemendaal AFT, Staring ABP, Mulder CL. 2017. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial. Lancet Psychiatry. 4(3):199–207.
   PubMed Web of Science ®Google Scholar
• Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. 2010. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 176(2-3):109–113.
   PubMed Web of Science ®Google Scholar
• Oberjé EJM, De Kinderen RJA, Evers S, Van Woerkum CMJ, De Bruin M. 2013. Cost effectiveness of medication adherence-enhancing interventions: A systematic review of trial-based economic evaluations. Pharmacoeconomics. 31(12):1155–1168.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. 2005. Adherence to medication. N Engl J Med. 353(5):487–497.
   PubMed Web of Science ®Google Scholar
• Priebe S, Bremner SA, Lauber C, Henderson C, Burns T. 2016. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial. Health Technol Assess. 20(70):1–122.
   PubMed Web of Science ®Google Scholar
• Priebe S, Burton A, Ashby D, Ashcroft R, Burns T, David A, Eldridge S, Firn M, Knapp M, McCabe R, et al. 2009. Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT). BMC Psychiatry. 9(1):61.
   PubMedGoogle Scholar
• Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J, Glick H, Liljas B, Petitti D, et al. 2005. Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report. Value Health. 8(5):521–533.
   PubMed Web of Science ®Google Scholar
• Readdean KC, Heuer AJ, Scott Parrott J. 2018. Effect of pharmacist intervention on improving antidepressant medication adherence and depression symptomology: a systematic review and meta-analysis. Res Soc Adm Pharm. 14(4):321–331.
   PubMed Web of Science ®Google Scholar
• Reid KJ, Aguilar KM, Miller RM. 2015. Value-based benefit design to improve medication adherence for employees with anxiety or depression. Am Heal Drug Benefits. 8(5):263–271.
   PubMed Web of Science ®Google Scholar
• Robertson AG, Swanson JW, Van Dorn RA, Swartz MS. 2014. Treatment participation and medication adherence: Effects on criminal justice costs of persons with mental illness. Psychiatr Serv. 65(10):1189–1191.
   PubMed Web of Science ®Google Scholar
• Rootes-Murdy K, Glazer KL, Van Wert MJ, Mondimore FM, Zandi PP. 2018. Mobile technology for medication adherence in people with mood disorders: a systematic review. J Affect Disord. 227:613–617.
   PubMed Web of Science ®Google Scholar
• Rubio-Valera M, Bosmans J, Fernández A, Peñarrubia-María M, March M, Travé P, Bellón JA, Serrano-Blanco A. 2013. Cost-effectiveness of a community pharmacist intervention in patients with depression: a randomized controlled trial (PRODEFAR Study). PLoS One. 8(8):e70588.
   PubMed Web of Science ®Google Scholar
• Rubio-Valera M, Serrano-Blanco A, Travé P, Peñarrubia-María MT, Ruiz M, Pujol MM. 2009. Community pharmacist intervention in depressed primary care patients (PRODEFAR study): randomized controlled trial protocol. BMC Public Health. 9:284.
   PubMed Web of Science ®Google Scholar
• Ruppar TM, Dobbels F, Lewek P, Matyjaszczyk M, Siebens K, De Geest SM. 2015. Systematic review of clinical practice guidelines for the improvement of medication adherence. Int J Behav Med. 22(6):699–708.
   PubMed Web of Science ®Google Scholar
• Sensharma A, Yabroff KR. 2019. Do interventions that address patient cost-sharing improve adherence to prescription drugs? A systematic review of recently published studies. Expert Rev Pharmacoecon Outcomes Res. 19(3):263–277.
   PubMed Web of Science ®Google Scholar
• Shemilt I, Thomas J, Morciano M. 2010. A web-based tool for adjusting costs to a specific target currency and price year. Evid Policy A J Res Debate Pract. 6(1):51–59.
   Google Scholar
• Simon-Tuval T, Neumann PJ, Greenberg D. 2016. Cost-effectiveness of adherence-enhancing interventions: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 16(1):67–84.
   PubMed Web of Science ®Google Scholar
• Steinkamp JM, Goldblatt N, Borodovsky JT, LaVertu A, Kronish IM, Marsch LA, Schuman-Olivier Z. 2019. Technological interventions for medication adherence in adult mental health and substance use disorders: a systematic review. JMIR Ment Health. 6(3):e12493.
   PubMed Web of Science ®Google Scholar
• Thieda P, Beard S, Richter A, Kane J. 2003. An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatr Serv. 54(4):508–516.
   PubMed Web of Science ®Google Scholar
• Torres-Robles A, Wiecek E, Tonin FS, Benrimoj SI, Fernandez-Llimos F, Garcia-Cardenas V. 2018. Comparison of interventions to improve long-term medication adherence across different clinical conditions: a systematic review with network meta-analysis. Front Pharmacol. 9:1454.
   PubMed Web of Science ®Google Scholar
• Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP. 2010. Strategies for addressing adherence problems in patients with serious and persistent mental illness: Recommendations from the expert consensus guidelines. J Psychiatr Pract. 16(5):306–324.
   PubMed Web of Science ®Google Scholar
• Vergouwen ACM, Bakker A, Katon WJ, Verheij TJ, Koerselman F. 2003. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 64(12):1415–1420.
   PubMed Web of Science ®Google Scholar
• von Knorring L, Åkerblad AC, Bengtsson F, Carlsson Å, Ekselius L. 2006. Cost of depression: effect of adherence and treatment response. Eur Psychiatry. 21(6):349–354.
   PubMed Web of Science ®Google Scholar
• Wade AG, Häring J. 2010. A review of the costs associated with depression and treatment noncompliance: The potential benefits of online support. Int Clin Psychopharmacol. 25(5):288–296.
   PubMed Web of Science ®Google Scholar
• Wiecek E, Tonin FS, Torres-Robles A, Benrimoj SI, Fernandez-Llimos F, Garcia-Cardenas V. 2019. Temporal effectiveness of interventions to improve medication adherence: a network meta-analysis. PLoS One. 14(3):e0213432.
   PubMed Web of Science ®Google Scholar